Although Petersen et al. have recently reported that the polymorphisms C-482T and T-455C in APOC3 are associatd with nonalcoholic fatty liver disease and insulin resistance, the association of APOC3 variants and NAFLD risk has not yet been validated by others so far. This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.